Skip to main content
Top
Published in: BMC Hematology 1/2018

Open Access 01-12-2018 | Research article

Infections in patients with aplastic Anemia in Chiang Mai University

Authors: Rapee Lertpongpiroon, Ekarat Rattarittamrong, Thanawat Rattanathammethee, Chatree Chai-Adisaksopha, Adisak Tantiworawit, Parichat Salee, Lalita Norasetthada

Published in: BMC Hematology | Issue 1/2018

Login to get access

Abstract

Background

Infection is a major complication in aplastic anemia (AA) patients. Primary objectives of this study were to determine the prevalence of infections and to determine types of pathogens associated with infections in patients with AA. Secondary objectives were to evaluate overall survival after infections as well as risk factors of infections in patients with AA.

Methods

The authors retrospectively evaluated the infectious episodes (IEs), type of infections, associated pathogens, and outcomes of infections in patients with AA who were diagnosed and treated at Chiang Mai University between January 2010 and December 2015.

Results

Sixty-seven patients with a median age of 51 years (range, 15–87 years) were enrolled. Forty two patients (62.6%) were severe AA. Median absolute neutrophil count (ANC) was 984 /mm3 (range, 120–5500/mm3). Twenty five patients (37.3%) received antithymocyte globulin plus cyclosporine A, 41 patients (61.1%) received anabolic hormone, and 2 patients (2.9%) underwent allogeneic hematopoietic stem cell transplantation. Overall, 31 IEs were documented in 22 patients (32.8%). The most common microbiologically documented site of infection was bloodstream infection (23.4%) followed by pulmonary infection (14.9%). Culture-negative febrile neutropenia occurred in 12.7%. Common pathogens identified were bacteria (73.9%), mainly gram-negative (52.9%) including Acinetobacter baumannii (23.5%) and Pseudomonas aeruginosa (17.6%). Fungal infections were diagnosed in 21.7% and all were Aspergillus spp. Six patients (9%) died during the study period. All of them died from infection which gram-negative bacteria were most common pathogens (66.7%). Patients with infections had 5-year overall survival of 72% that is significantly less than patients without infection (100%) (p = 0.0002). Only risk factor that correlates with high probability of infection was ANC < 500/mm3. (HR 2.29, 95%CI 1.03–7.72, p = 0.043).

Conclusions

Prevalence of infections in AA patients in Chiang Mai University was 32.8% Bacterial infections especially gram-negative bacteria were the major pathogens. Patients with ANC < 500/mm3 had higher risk of infections. Infection was the most important cause of death in AA.
Literature
4.
go back to reference Issaragrisil S, Leaverton PE, Chansung K, et al. Regional patterns in the incidence of aplastic anemia in Thailand. Am J Hematol. 1999;66:164–8.CrossRef Issaragrisil S, Leaverton PE, Chansung K, et al. Regional patterns in the incidence of aplastic anemia in Thailand. Am J Hematol. 1999;66:164–8.CrossRef
5.
go back to reference Torres HA, Bodey GP, Rolston KVI, et al. Infections in patients with aplastic anemia. Cancer. 2003;98:86–93.CrossRefPubMed Torres HA, Bodey GP, Rolston KVI, et al. Infections in patients with aplastic anemia. Cancer. 2003;98:86–93.CrossRefPubMed
6.
go back to reference Weinberger M, Elatter I, Marshall D, et al. Patterns of infections in patients with aplastic anemia and the emergence of aspergillus as a major cause of death. Medicine (Baltimore). 1992;71:24–43.CrossRef Weinberger M, Elatter I, Marshall D, et al. Patterns of infections in patients with aplastic anemia and the emergence of aspergillus as a major cause of death. Medicine (Baltimore). 1992;71:24–43.CrossRef
7.
go back to reference Valdez JM, Scheinberg P, Nunez O, et al. Decreased infection-related mortality and improved survival in severe aplastic anemia in the past two decades. Clin Infect Dis. 2011;52:726–35.CrossRefPubMedPubMedCentral Valdez JM, Scheinberg P, Nunez O, et al. Decreased infection-related mortality and improved survival in severe aplastic anemia in the past two decades. Clin Infect Dis. 2011;52:726–35.CrossRefPubMedPubMedCentral
8.
go back to reference Issaragrisil S, Seksan P, Nawarawong W, et al. Guidelines for diagnosis and management of aplastic anemia. In: Seksan P, Nawarawong W, Intragumtornchai T, editors. Thai guideline for management of hematologic diseases. The Thai Society of Hematology. Bangkok: Num Aksorn Publishing; 2011. Issaragrisil S, Seksan P, Nawarawong W, et al. Guidelines for diagnosis and management of aplastic anemia. In: Seksan P, Nawarawong W, Intragumtornchai T, editors. Thai guideline for management of hematologic diseases. The Thai Society of Hematology. Bangkok: Num Aksorn Publishing; 2011.
9.
go back to reference Freifeld AG, Bow EJ, Sepkowitz KA, et al. Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 update by the Infectious Diseases Society of America. Clin Infect Dis. 2011;52:e56–93.CrossRefPubMed Freifeld AG, Bow EJ, Sepkowitz KA, et al. Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 update by the Infectious Diseases Society of America. Clin Infect Dis. 2011;52:e56–93.CrossRefPubMed
10.
go back to reference Levy MM, Fink MP, Marshall JC, et al. 2001 SCCM/ESICM/ACCP/ATS/SIS international Sepsis definitions conference. Crit Care Med. 2003;31:1250–6.CrossRefPubMed Levy MM, Fink MP, Marshall JC, et al. 2001 SCCM/ESICM/ACCP/ATS/SIS international Sepsis definitions conference. Crit Care Med. 2003;31:1250–6.CrossRefPubMed
11.
go back to reference Pauw BD, Walsh TJ, Donnelly JP. Revised definitions of invasive fungal disease from the European organization for research and treatment of cancer: invasive fungal infections cooperative group and the National Institute of Allergy and Infectious Diseases mycoses study group (EORTC/MSG) consensus group. Clin Infect Dis. 2008;46:1813–21.CrossRefPubMed Pauw BD, Walsh TJ, Donnelly JP. Revised definitions of invasive fungal disease from the European organization for research and treatment of cancer: invasive fungal infections cooperative group and the National Institute of Allergy and Infectious Diseases mycoses study group (EORTC/MSG) consensus group. Clin Infect Dis. 2008;46:1813–21.CrossRefPubMed
12.
13.
go back to reference Rosenfeld SJ, Kimball J, Vining D, Young NS. Intensive immunosuppression with antithymocyte globulin and cyclosporine as treatment for severe acquired aplastic anemia. Blood. 1995;85:3058–65.PubMed Rosenfeld SJ, Kimball J, Vining D, Young NS. Intensive immunosuppression with antithymocyte globulin and cyclosporine as treatment for severe acquired aplastic anemia. Blood. 1995;85:3058–65.PubMed
14.
go back to reference Risitano AM. Immunosuppressive therapies in the management of immune-mediated marrow failures in adults: where we stand and where we are going. Br J Haematol. 2011;152:127–40.CrossRefPubMed Risitano AM. Immunosuppressive therapies in the management of immune-mediated marrow failures in adults: where we stand and where we are going. Br J Haematol. 2011;152:127–40.CrossRefPubMed
15.
go back to reference Kekre N, Zhang Y, Zhang MJ, et al. Effect of antithymocyte globulin source on outcomes of bone marrow transplantation for severe aplastic anemia. Haematologica. 2017;102:1291–8.CrossRefPubMedPubMedCentral Kekre N, Zhang Y, Zhang MJ, et al. Effect of antithymocyte globulin source on outcomes of bone marrow transplantation for severe aplastic anemia. Haematologica. 2017;102:1291–8.CrossRefPubMedPubMedCentral
16.
go back to reference Fournier PE, et al. The epidemiology and control of Acinetobacter baumanii in health care facilities. Clin Infect Dis. 2006;42:692–9.CrossRefPubMed Fournier PE, et al. The epidemiology and control of Acinetobacter baumanii in health care facilities. Clin Infect Dis. 2006;42:692–9.CrossRefPubMed
17.
go back to reference Flowers CR, Seidenfeld J, Bow EJ, et al. Antimicrobial prophylaxis and outpatient management of fever and neutropenia in adults treated for malignancy: American Society of Clinical Oncology clinical practice guideline. J Clin Oncol. 2013;31:794–810.CrossRefPubMed Flowers CR, Seidenfeld J, Bow EJ, et al. Antimicrobial prophylaxis and outpatient management of fever and neutropenia in adults treated for malignancy: American Society of Clinical Oncology clinical practice guideline. J Clin Oncol. 2013;31:794–810.CrossRefPubMed
18.
go back to reference Killick SB, Bown N, Cavenagh J, et al. Guidelines for the diagnosis and management of adult aplastic anaemia. Br J Haematol. 2016;172:187–207.CrossRefPubMed Killick SB, Bown N, Cavenagh J, et al. Guidelines for the diagnosis and management of adult aplastic anaemia. Br J Haematol. 2016;172:187–207.CrossRefPubMed
Metadata
Title
Infections in patients with aplastic Anemia in Chiang Mai University
Authors
Rapee Lertpongpiroon
Ekarat Rattarittamrong
Thanawat Rattanathammethee
Chatree Chai-Adisaksopha
Adisak Tantiworawit
Parichat Salee
Lalita Norasetthada
Publication date
01-12-2018
Publisher
BioMed Central
Published in
BMC Hematology / Issue 1/2018
Electronic ISSN: 2052-1839
DOI
https://doi.org/10.1186/s12878-018-0129-9

Other articles of this Issue 1/2018

BMC Hematology 1/2018 Go to the issue